Game-Changer Breakthrough. Can CRISPR Therapeutics Soar?
In recent years, CRISPR Therapeutics has faced a tough market, with its stock struggling to gain traction. Despite the setbacks, there are promising updates that could change the company’s future trajectory. Expanding Horizons with Casgevy CRISPR Therapeutics, in collaboration with Vertex Pharmaceuticals,